Methylenedioxybutylamphetamine
Names
Preferred IUPAC name
N-[1-(2H-1,3-Benzodioxol-5-yl)propan-2-yl]butan-1-amine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C14H21NO2/c1-3-4-7-15-11(2)8-12-5-6-13-14(9-12)17-10-16-13/h5-6,9,11,15H,3-4,7-8,10H2,1-2H3
    Key: RDXVRDCQDITVDV-UHFFFAOYSA-N
  • C1=C2C(=CC=C1CC(C)NCCCC)OCO2
Properties
C14H21NO2
Molar mass 235.327 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Methylenedioxybutylamphetamine (MDBU or 3,4-methylenedioxy-N-butylamphetamine) is a lesser-known psychedelic drug. It is also the N-butyl derivative of 3,4-methylenedioxyamphetamine (MDA). MDBU was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 40 mg, and the duration unknown.[1] MDBU produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDBU.

See also

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.